The mesenchymal stem cell marker CD248 (endosialin) is a negative regulator of bone formation in mice.

OBJECTIVE CD248 (tumor endothelial marker 1/endosialin) is found on stromal cells and is highly expressed during malignancy and inflammation. Studies have shown a reduction in inflammatory arthritis in CD248-knockout (CD248(-/-) ) mice. The aim of the present study was to investigate the functional effect of genetic deletion of CD248 on bone mass. METHODS Western blotting, polymerase chain reaction, and immunofluorescence were used to investigate the expression of CD248 in humans and mice. Micro-computed tomography and the 3-point bending test were used to measure bone parameters and mechanical properties of the tibiae of 10-week-old wild-type (WT) or CD248(-/-) mice. Human and mouse primary osteoblasts were cultured in medium containing 10 mM β-glycerophosphate and 50 μg/ml ascorbic acid to induce mineralization, and then treated with platelet-derived growth factor BB (PDGF-BB). The mineral apposition rate in vivo was calculated by identifying newly formed bone via calcein labeling. RESULTS Expression of CD248 was seen in human and mouse osteoblasts, but not osteoclasts. CD248(-/-) mouse tibiae had higher bone mass and superior mechanical properties (increased load required to cause fracture) compared to WT mice. Primary osteoblasts from CD248(-/-) mice induced increased mineralization in vitro and produced increased bone over 7 days in vivo. There was no decrease in bone mineralization and no increase in proliferation of osteoblasts in response to stimulation with PDGF-BB, which could be attributed to a defect in PDGF signal transduction in the CD248(-/-) mice. CONCLUSION There is an unmet clinical need to address rheumatoid arthritis-associated bone loss. Genetic deletion of CD248 in mice results in high bone mass due to increased osteoblast-mediated bone formation, suggesting that targeting CD248 in rheumatoid arthritis may have the effect of increasing bone mass in addition to the previously reported effect of reducing inflammation.

[1]  C. Isacke,et al.  CD248+ stromal cells are associated with progressive chronic kidney disease. , 2011, Kidney international.

[2]  J. Tavernier,et al.  CD248 and its cytoplasmic domain: a therapeutic target for arthritis. , 2010, Arthritis & Rheumatism.

[3]  Geert Carmeliet,et al.  Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. , 2010, Developmental cell.

[4]  C. Isacke,et al.  The pericyte and stromal cell marker CD248 (endosialin) is required for efficient lymph node expansion , 2010, European journal of immunology.

[5]  Simon R. Goodyear,et al.  PHOSPHO1 is essential for mechanically competent mineralization and the avoidance of spontaneous fractures. , 2010, Bone.

[6]  Nicolas C. Nicolaides,et al.  Endosialin/TEM-1/CD248 regulates pericyte proliferation through PDGF receptor signaling , 2010, Cancer biology & therapy.

[7]  B. Teicher,et al.  Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers. , 2009, International journal of oncology.

[8]  B. Teicher,et al.  Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization. , 2008, Microvascular research.

[9]  B. Hoflack,et al.  Osteoclasts Control Osteoblast Chemotaxis via PDGF-BB/PDGF Receptor Beta Signaling , 2008, PloS one.

[10]  Y. Ishii,et al.  PDGF Receptor β Is a Potent Regulator of Mesenchymal Stromal Cell Function , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  B. Foley,et al.  Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration , 2007, Proceedings of the National Academy of Sciences.

[12]  J. Cornish,et al.  Imatinib Promotes Osteoblast Differentiation by Inhibiting PDGFR Signaling and Inhibits Osteoclastogenesis by Both Direct and Stromal Cell‐Dependent Mechanisms , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  G. Ehninger,et al.  Inhibition of platelet‐derived growth factor receptorβ by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro , 2007, Cell proliferation.

[14]  C. Isacke,et al.  Endosialin is expressed on stromal fibroblasts and CNS pericytes in mouse embryos and is downregulated during development. , 2007, Gene expression patterns : GEP.

[15]  R. Schwendener,et al.  Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy. , 2006, Cancer letters.

[16]  K. Kinzler,et al.  Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Linheng Li,et al.  Stem cell niche: structure and function. , 2005, Annual review of cell and developmental biology.

[18]  C. Isacke,et al.  Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium , 2005, FEBS letters.

[19]  S. Batalov,et al.  A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  W. A. Yeudall,et al.  Accelerated Cell Cycle Progression in Osteoblasts Overexpressing the c-fos Proto-oncogene , 2004, Journal of Biological Chemistry.

[21]  J. M. Somerville,et al.  Growth of C57Bl/6 Mice and the Material and Mechanical Properties of Cortical Bone from the Tibia , 2004, Calcified Tissue International.

[22]  Antal Rot,et al.  Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions , 2004, Platelets.

[23]  D. Brenner,et al.  DNase I–hypersensitive sites enhance α1(I) collagen gene expression in hepatic stellate cells , 2003 .

[24]  J. Aubin,et al.  The mature osteoblast phenotype is characterized by extensive plasticity. , 1997, Experimental cell research.

[25]  J. Compston,et al.  Distribution of platelet-derived growth factor (PDGF) A chain mRNA, protein, and PDGF-alpha receptor in rapidly forming human bone. , 1996, Bone.

[26]  L. Donahue,et al.  Genetic variability in adult bone density among inbred strains of mice. , 1996, Bone.

[27]  D. Graves,et al.  Pro‐inflammatory cytokines downregulate platelet derived growth factor‐α receptor gene expression in human osteoblastic cells , 1996, Journal of cellular physiology.

[28]  D. Brenner,et al.  Far upstream regulatory elements enhance position-independent and uterus-specific expression of the murine alpha1(I) collagen promoter in transgenic mice. , 1999, Gene expression.